Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. Monocyte influx and activation in synovial joints are important in the pathogenesis of both degenerative and inflammatory arthropathies. In this study, we demonstrate the potential of articular cartilage to directly modulate these events. IL-1-stimulated human articular chondrocytes transcribed 0.7-kb monocyte chemoattractant protein-1 (MCP-1) mRNA. In situ hybridization of cartilage organ cultures revealed MCP-1 transcripts in chondrocytes in the superficial tangential zone within 2 h of stimulation with IL-1. Chondrocytes in deeper layers responded by 4 h and reached maximum MCP-1 mRNA levels by 8-12 h. IL-1-stimulated cartilage organ and chondrocyte monolayer cultures released functional monocyte chemotactic activity. This was neutralized by a monoclonal antibody specific for MCP-1, and was associated with the synthesis and secretion of immunoreactive 13-kD and 15-kD isoforms of MCP-1. Regulators and signal transduction pathways involved with the expression of the MCP-1 gene in chondrocytes were analyzed. Steady-state mRNA levels were increased by the known chondrocyte activators IL-1, tumor necrosis factor alpha, LPS, platelet-derived growth factor, and transforming growth factor beta. In addition, leukemia inhibitory factor induced MCP-1 gene expression and protein synthesis, identifying this cytokine as a new regulator of chondrocyte function. Dexamethasone blunted the induction of MCP-1 gene expression by IL-1 and by activators of protein kinase A as well as protein kinase C signal transduction pathways. In contrast, retinoic acid strongly increased phorbol myristate […] 
Introduction
Monocyte influx and activation in synovial joints are important in the pathogenesis of both degenerative and inflammatory arthropathies. In this study, we demonstrate the potential ofarticular cartilage to directly modulate these events.
IL-1-stimulated human articular chondrocytes transcribed 0.7-kb monocyte chemoattractant protein-1 (MCP-1) mRNA. In situ hybridization of cartilage organ cultures revealed MCP-1 transcripts in chondrocytes in the superficial tangential zone within 2 h of stimulation with IL-1. Chondrocytes in deeper layers responded by 4 h and reached maximum MCP-1 mRNA levels by 8-12 h. IL-i-stimulated cartilage organ and chondrocyte monolayer cultures released functional monocyte chemotactic activity. This was neutralized by a monoclonal antibody specific for MCP-1, and was associated with the synthesis and secretion of immunoreactive 13-kD and 15-kD isoforms of MCP-1.
Regulators and signal transduction pathways involved with the expression of the MCP-1 gene in chondrocytes were analyzed. Steady-state mRNA levels were increased by the known chondrocyte activators IL-1, tumor necrosis factor alpha, LPS, platelet-derived growth factor, and transforming growth factor beta. In addition, leukemia inhibitory factor induced MCP-1 gene expression and protein synthesis, identifying this cytokine as a new regulator of chondrocyte function. Dexamethasone blunted the induction ofMCP-1 gene expression by IL-1 and by activators of protein kinase A as well as protein kinase C signal transduction pathways. In contrast, retinoic acid strongly increased phorbol myristate acetate-induced MCP-1 expression and potentiated the effects of IL-I and LPS.
In conclusion, chondrocytes express MCP-1 in response to factors that are present in cartilage or synovium. This provides a mechanism by which cartilage can play an active role in the initiation and progression of arthritis. (J. Clin. Invest. 1992. 90:488496.) Key words: chondrocytes * cartilage . monocyte chemoattractant protein-1 -leukemia inhibitory factor * transforming growth factor beta * retinoic acid Arthritis is generally viewed as a process that is based on the infiltration of synovial tissue and/or fluid with inflammatory cells that cause acute symptoms and lead to degradation of cartilage. In this scenario, cartilage is seen as the passive target ofsynovial inflammation, a notion that has been revised by the demonstration that chondrocytes are secretory cells that produce not only proteases ( 1 ) but also multiple regulatory factors that can act on cartilage, synovium, or on leukocytes infiltrating the joint (2) (3) (4) (5) (6) .
Synovial fluid monocytosis is a finding characteristic of osteoarthritis (7) a disease originating in and primarily affecting cartilage. Furthermore, intraarticular monocyte infiltration and activation are thought to be important events in the pathogenesis ofcartilage degradation in inflammatory and degenerative arthropathies. Monocyte recruitment in arthritides may be initiated by a variety ofchemotactic factors derived from articular tissues, including type II collagen peptides released by proteolysis of cartilage (8) , and transforming growth factor beta (TGF3)' and platelet-derived growth factor (PDGF) secreted from synoviocytes and chondrocytes (5, 6) . In this study, we examine the ability of articular cartilage to express monocyte chemoattractant protein (MCP-l ), a more recently identified cytokine (9) (10) (11) (12) (13) that is a member of a family of small, proinflammatory polypeptides that includes platelet factor 4 and IL-8 (14, 15) . MCP-1 is specifically recognized by monocytes, stimulating not only chemotaxis but also the release of superoxide and lysosomal proteases (16) . MCP-1 is secreted as a 76-amino acid glycoprotein that migrates typically in two molecular forms ( 13 and 15 kD) on SDS-PAGE under reducing conditions (12) . The gene for MCP-1 has been cloned, and some of its regulatory elements have been characterized ( 17) .
Although multiple inducers and cell sources ofMCP-1 have been characterized, expression by joint tissue cells is largely unknown. This study demonstrates that chondrocytes express the MCP-1 gene and that MCP-l is the major monocyte chemotactant in IL-1-stimulated cartilage organ culture. Regulatory factors that are known to be present in cartilage or synovium can induce MCP-1 gene expression by chondrocytes in monolayer and organ culture. New agents and pathways in-volved with the induction of MCP-1 in chondrocytes are identified.
Methods
Chondrocyte isolation and culture. Cartilage was obtained at autopsy from donors without known history of joint disease. For all experiments reported here, cartilage from the femoral condyles and tibial plateaus ofthe knee joints was used. Cartilage slices were prepared and washed with DMEM (Whittaker M.A. Bioproducts, Walkersville, MD). They were minced with a scalpel and treated with trypsin (10% vol/vol) for 15 min in a 370C waterbath. The samples were transferred to DMEM containing 5% fetal bovine serum (FBS), penicillin-streptomycin-fungizone, and 2 mg/ml clostridial collagenase type IV (Sigma Chemical Co., St. Louis, MO) and digested for 3 h on agyratory shaker until the tissue fragments were dissolved. The cells were washed three times and cultured as primary chondrocytes. For cartilage organ culture experiments, slices ofknee cartilage of0.5 X 0.5 X 0.3-cm size were prepared. Care was taken not to disturb the surface and to obtain full thickness cartilage. Slices were weighed and cultured in 12-well plates in DMEM 1% FBS. For studies on gene expression chondrocytes were used as primary or subcultured cells as indicated for each experiment.
Chemotaxis assay. Enriched preparations of human peripheral blood monocytes were isolated from the heparin-anticoagulated venous blood of normal volunteers. First, mononuclear leukocytes were separated by centrifugation at 400 g for 30 min over Ficoll-Hypaque, washed three times, and resuspended in RPMI 1640 that contained 10% FBS. 3-ml aliquots of mononuclear leukocytes were carefully layered over a discontinuous Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) density gradient (5.0 ml 30% Percoll; 5.0 ml 40% Percoll; 15.0 ml 50.5% Percoll; 7.5 ml 75% Percoll) in 50-ml centrifuge tubes.
After centrifugation at 400 g for 30 min at 220C, the monocyteenriched fraction was removed from the 40-50.5% interface of each gradient. Monocyte enrichment was typically > 85% under these conditions, as assessed by staining with the mature monocyte marker Mo2 (CD14).
The monocyte-enriched fraction was washed three times in RPMI RNA probe preparation. The cDNA for MCP-I inserted in EcoRI sites ofpBS-SK(-) was kindly provided by Drs. Ed Leonard and Teizo Yoshimura, National Cancer Institute, Fredrick, MD. For development of a probe for fl-actin, two 1 5-bp oligonucleotides (5'-CGTCGTCGACAACGG-3' and 5'-GACCGTAGCACTACC-3') defining a 216-bp fragment of the cDNA were designed. The restriction sites EcoRI and HindIl were added at their 5' ends, respectively. After amplification by polymerase chain reaction the fragment was inserted into pGEM-4z (Promega Corp., Madison, WI).
The recombinant plasmids were linearized and transcribed with the T7 or T3 RNA polymerase to obtain antisense and sense probes, respectively. For Northern blotting, the probes were labeled with [32P]UTP (Amersham) and separated from unincorporated nucleotides by gel filtration (Centri-sep columns; Princeton Separations, Inc., Adelphia, NJ). The probes for in situ hybridization were generated in the presence of 35S-UTP. After transcription, the template was digested with DNase and the products were recovered by phenol extraction and ethanol precipitation. The specific activity was -2 x 108 dpm/,ug template.
Northern blot hybridization. Primary or subcultured (P1 to P8) chondrocytes were maintained in T175 flasks and stimulated as indicated for each experiment. Total RNA was extracted by the single step guanidinium thiocyanate-phenol-chloroform method (20). 10-30 Mg of total RNA was separated on 1% formaldehyde gels, blotted onto nylon filters, and cross-linked with UV light for 5 min each side. The blots were prehybridized in 50% formamide, 6x standard saline citrate (SSC), 0.5% SDS, 0.1% Tween 20, 100Mg yeast RNA/ml for 15 min at 65°C. The prehybridization mixture was replaced with fresh solution containing 106 cpm/ml of probe. Hybridization was performed overnight at 65°C and followed by washes in lX SSC, 0.1% SDS at room temperature (2 x 30 min) and 0.1X SSC, 0.1% SDS at 65°C (2 X 30 min). The damp filters were exposed to Kodak XAR film at -70°C for 2-24 h. To confirm equal RNA load and complete transfer the 18S and 28S bands were visualized with ethidium bromide on all filters. In addition, RNA load was examined by probing for ,B-actin mRNA. For most aspects ofMCP-1 mRNA expression at least three separate experiments were performed.
In situ hybridization. Cartilage organ cultures were prepared as outlined above. After appropriate incubation time the slices were cut perpendicular to the surface into two pieces of equal size. They were snap frozen in dry ice/2-methyl-butane and stored at -70°C until use. Frozen sections (5 Mm) were cut and mounted onto precleaned slides (Fisher Scientific, San Francisco, CA). They were fixed in 4% paraformaldehyde, washed in lx PBS, and transferred to 2x SSC. Hybridization was performed as described elsewhere (21) . In brief, the specimens were acetylated in triethanolamine with acetic anhydride and incubated in glycine buffer. Hybridization was carried out with I0 cpm/Al ofprobe in 50% formamide, 3x SSC, 500 Mug/ml yeast tRNA, 1 mg/ml single-stranded calf thymus DNA, 2 mg/ml BSA, 10 mM DTT, and 1% polyethylene glycol overnight at 50°C. Posthybridization treatment consisted of washes with 2x SSC, 50% formamide at 50°C, incubation with RNase solution and further washes in 2X SSC at 55°C and thereafter in 2x SSC at room temperature. Specimens were dehydrated, air-dried, and covered with Kodak NTB nuclear track emulsion (Eastman Kodak) for autoradiography. After (Fig. 1) . Conditioned media from 24-h cultures were tested since this is an optimal time point for the induction of cytokine release by IL-1 in chondrocytes. The chemotactic activity of both rMCP-1 and the conditioned media of IL-1-stimulated cartilage, were nearly completely abrogated by pretreatment with a monoclonal, neutralizing antibody to MCP-1, but not with nonimmune murine IgG (Fig.  1) . Specificity of this assay system for MCP-1-induced monocyte chemotaxis was validated by: (a) establishing that the human neutrophil and T lymphocyte chemotactant, IL-8 (10 nM) did not induce a chemotactic response (not shown); and (b) the lack of a neutralizing effect of identical pretreatment of 10 nM FMLP with monoclonal anti-MCP-1 antibody on the elicited monocyte chemotaxis response (90±3 monocytes/five high power fields without anti-MCP-1, 110±18 monocytes/ five high power fields with anti-MCP-1, n = 3). Furthermore, the addition of IL-1 in doses up to 10 ng/ml to culture media did not induce detectable monocyte chemotaxis. Thus, activated chondrocytes in organ culture secreted biologically active MCP-1, which was the predominant chemoattractant for monocytes in their conditioned media.
Pattern of chondrocyte MCP-J mRNA expression in response to IL-I in cartilage organ culture. Many parameters of the responsiveness ofchondrocytes within cartilage to stimulation with IL-I have not previously been characterized. To examine kinetics, the distribution and number of cells that express MCP-1 mRNA, cartilage fragments of identical size and shape containing all layers of the tissue, were cut and cultured in the presence or absence of IL-1 (10 ng/ml). Fig. 2 shows that unstimulated cells (Co) remained negative for MCP-l mRNA as assayed by in situ hybridization. By 2 h after stimulation with IL-1, the majority of the cells in the superficial tangential zone showed some positivity for MCP-l mRNA (white granules are covering cells in dark-field picture). However, by 4 Chondrocytes synthesize and release the 13-and 15-kD isoforms of MCP-J. IL-1-activated cartilage expressed MCP-l mRNA and secreted biologically active MCP-1. We next analyzed whether activated chondrocytes synthesize this cytokine and characterized the MCP-1 proteins produced. Primary chondrocytes were cultured in the presence of [35S ] methionine and [35S]cysteine for 48 h, and stimulated with IL-1 (10 ng/ ml) or LIF (10 ng/ml). Conditioned media were immunoprecipitated, and analyzed by a 15% SDS-PAGE under reducing conditions (Fig. 3) . Chondrocytes synthesized two isoforms of MCP-1 in similar quantity, and ofthe characteristic 1 3-kD and 15-kD sizes ( 12). Stimulation with not only IL-1, but also with LIF induced a marked increase in the intensity of the bands, demonstrating upregulation ofprotein synthesis in response to these cytokines.
Regulation ofMCP-J gene expression in chondrocytes. We further evaluated regulation of MCP-1 expression using cultured chondrocytes. Northern blot analysis showed that pri- mary chondrocytes cultured in the presence of serum consistently expressed 0.7-kb MCP-l mRNA (see results below). This decreased to low levels after overnight serum-starvation (Fig. 4, lane 1) and remained low over a period ofat least 48 h (not shown). IL-Ifl, TNFa, and LPS (lanes 2, 5, and 6, respectively) induced a marked increase in MCP-l mRNA levels while IL-6, an important regulator of chondrocyte function (22, 23) had no detectable effect (lane 3). Surprisingly, LIF caused only a slight increase in MCP-l mRNA level at 5 h (lane 4). This was not expected because of the marked effect of LIF on MCP-1 synthesis (Fig. 3) and suggested that the kinetics of MCP-l expression in response to LIF differed from the kinetics in response to IL-1.
We thus compared the kinetics of MCP-l mRNA expression in response to IL-1, LIF, and TGF,3 (Fig. 5 ) , and observed that LIF induced a very rapid increase in MCP-1 mRNA, which reached its maximal levels by 2 h. By 5 h, the mRNA levels had already returned to baseline (Fig. 5 B) . As we recently showed that LIF increases the expression ofLIF mRNA (24) the same blot that had been probed for MCP-l was hybridized to a labeled LIF RNA probe. This showed that in contrast to MCP-1, LIF mRNA levels remain elevated for at least 9 h. The very rapid and transient induction ofhigh MCP-l mRNA levels by LIF was confirmed in two additional experiments. (25 ) . Fig. 6 A shows that chondrocyte culture in 1% FBS is sufficient to induce detectable levels of MCP-l mRNA (lane 1). Dexamethasone (lane 3) abrogated the serum-induced MCP-l gene expression and markedly reduced the response to IL-l (lane 4). In addition, dexamethasone inhibited MCP-1 expression in response to cAMP and to PMA (Fig. 6 B) . Thus, dexamethasone is a general inhibitor of MCP-I expression in chondrocytes inhibiting serum-induced (basal) and inducible gene expression.
Retinoic acid (RA) has potent effects on differentiation of mesoderm-derived tissues (26) and inhibits IL-l-induced expression of collagenase and stromelysin and production of proinflammatory cytokines (27) (28) (29) . Having established that chondrocytes can produce MCP-1, this study defined characteristics ofexpression ofthis gene that are important or unique to cartilage. The first point addressed the role of extracellular matrix in the induction and secretion of MCP-1. We have demonstrated that cells in cartilage organ cultures are not only induced to produce MCP-1, but that biologically active MCP-1 is secreted from the tissue into the culture media. Although MCP-l is a heparin-binding protein, substantial amounts of this cytokine were released from cartilage, which contains a proteoglycan-rich matrix. The func- Fig. 7 B, RA not only elevated serum-induced MCP-1 expression but also markedly upregulated the MCP-l response to IL-1, LPS, and PMA (Fig. 7 B) . To test whether this effect was limited to MCP-1 gene expression or was a more general phenomenon the same Northern blot was sequentially probed for IL-6, IL-8, and LIF mRNAs. With all stimuli that induce expression of these cytokines a marked upregulation by RA was observed. Thus, in contrast to its effect on cytokine expression in monocytes (29) (30) , also needs to be evaluated. In situ hybridization experiments provided new insight into the kinetics and distribution of IL-l effects on chondrocyte gene expression in cartilage organ cultures. Cells in the superficial tangential zone expressed MCP-l already 2 h after stimulation with IL-1. This response was transient and mRNA levels had already decreased after 4 h. Interestingly, the response of the cells in the deeper layers ofcartilage was not only delayed in onset but of much longer duration. Since the effect of IL-l alone on MCP-1 is usually fast and brief, the prolonged expression by chondrocytes in deeper layers may be due to secondary events. One interesting hypothesis is that this may be due to the expression of TGF,3 which can cause a similarly long lasting increase in MCP-1 mRNA levels. In previous studies we demonstrated that IL-l induces a late increase in TGF#lI and a rapid increase in TGF,33 mRNA levels in chondrocytes (5). These differences in the kinetics ofMCP-I expression may also be indicative offunctional heterogeneity ofchondrocytes in the different layers of cartilage.
The characterization of inducers of MCP-I expression that are present in cartilage or synovium resulted in the identification of two peptide regulatory factors as new activators of this gene. In addition to IL-1, TNFa, LPS, PDGF, and serum, previously known inducers ofMCP-1 in other cell types, we demonstrate that TGF3 and LIF stimulate this cytokine in chondrocytes. Except for the induction of bone resorption in vivo and in vitro (31, 32) , LIF has not yet been characterized with respect to its effects on connective tissue metabolism. The finding that LIF induces MCP-l expression represents the first documentation that LIF can regulate the synthesis of other cytokines and that it affects chondrocyte function. We recently showed that chondrocytes and synoviocytes produce LIF and that synovial fluids contain LIF activity (24) . Based on its presence in the joint, LIF is probably an important inducer of chondrocyte MCP-l production in vivo.
TGFB is abundant in inflammatory joint fluids (33, 34) . It is a potent regulator of chondrocyte function and also known to profoundly affect specific as well as nonspecific immune reactions (reviewed in 35). In cartilage TGF# has mainly anabolic functions. It promotes chondrocyte proliferation (5, 23) , the synthesis of extracellular matrix (36) and it reduces IL-l induction ofcollagenase (37) and the expression ofIL-1 receptors on chondrocytes (38) . Among its effects on immune responses, TGFB has been shown to inhibit T and B lymphocyte proliferation, to modulate immunoglobulin synthesis and to deactivate monocytes. In contrast to these antiinflammatory actions are the potent effects of TGFB as a neutrophil (39) and monocyte chemoattractant in vitro and in vivo (40, 41) . In addition, we showed recently that TGF,# induces production of the neutrophil chemoattractant, IL-8, by chondrocytes (4).
This study has demonstrated that TGF3 induces MCP-I mRNA levels comparable to the levels seen after stimulation with IL-1. Thus, TGF, can directly and indirectly contribute to the recruitment ofneutrophils and monocytes via the induction of IL-8 and MCP- 1. Two antiinflammatory steroids, dexamethasone and RA, which inhibit cytokine synthesis in other cell systems, were shown to differentially affect MCP-1 gene expression in chondrocytes. As has been shown for other cytokines and for MCP-1 in other cell types (25) , dexamethasone inhibited MCP-1 mRNA expression. Glucocorticoids bind to intracellular receptors that recognize glucocorticoid-responsive elements in the promoter regions ofgenes. In addition, glucocorticoids can modulate AP-l DNA binding activity and thereby inhibit gene expression (42) . Dexamethasone abrogated MCP-l mRNA induction after stimulation not only with IL-l but also in response to direct activators ofprotein kinase A (cAMP) and the protein kinase C (PMA) signal transduction pathways.
In contrast, RA was identified as a new and potent inducer of MCP-1 gene expression in chondrocytes. The effects of RA on gene expression depend on its binding to intracellular RA receptors. The RA/receptor complexes interact with retinoic acid response elements (RARE) in the promoter region ofseveral genes (43, 44). As for glucocorticoids, an interaction with AP-l binding proteins has been described (45, 46) . In the case of RA, the formation of unproductive complexes with c-Jun is thought to lead to a decrease in AP-l activity (47) . The promoter region of MCP-1 has recently been sequenced, but detailed analyses concerning functionally important regulatory elements are lacking. A phorbol ester responsive element (TRE) confers PMA responsiveness and this has been shown to be functionally important in fibroblasts ( 17) . Interestingly, PMA caused only a minimal increase in MCP-l mRNA in chondrocytes, but after preincubation of the cells for 3 d with RA, PMA induced a very strong increase in mRNA levels. In addition to the PMA response, MCP-l induction by IL-l and LPS was also upregulated by RA. These findings are in contrast to recent results obtained with human monocytes, where RA inhibited IL-1-induced synthesis of . This suggested that either the regulation ofIL-6 induction by IL-I differs from the regulation of MCP-1 by IL-1, or that there are cell-type specific factors which account for these contrasting results. Analysis ofgene expression ofother cytokines (IL-6, IL-8, LIF) revealed that the stimulated expression of all these cytokines was markedly upregulated in chondrocytes by pretreatment of the cells with RA. Furthermore, AP-I DNA-binding activity as analyzed by mobility shift assay documented that in chondrocytes RA treatment for 72 h resulted in an increase in AP-1 activity (unpublished results). Thus, the profound stimulatory effect of RA on expression of MCP-1 in chondrocytes, apparently represents a tissue specific difference in the effect of this agent on gene expression, and may be related to an increase in AP-1 activity.
In conclusion, through the production ofbiologically active 
